0
Articles |

Pharmacokinetic Study of α1-Antitrypsin Infusion in α1-Antitrypsin Deficiency

Alan F. Barker; Irene Iwata-Morgan; Lynn Oveson; Ralph Roussel
Author and Funding Information

Affiliations: From the Department of Medicine, Oregon Health Sciences University, Portland,  From the Bayer Corporation, Berkeley, Calif.

Affiliations: From the Department of Medicine, Oregon Health Sciences University, Portland,  From the Bayer Corporation, Berkeley, Calif.


1997 by the American College of Chest Physicians


Chest. 1997;112(3):607-613. doi:10.1378/chest.112.3.607
Text Size: A A A
Published online

Abstract

Objectives: To ascertain how long 120 mg/kg alpha1-antitrypsin concentrate (α1-AT-C), administered IV every 2 weeks, can maintain α1-antitrypsin (α1-AT) serum levels above 70 to 80 mg/dL. Secondary objectives were to summarize the nature, severity, and relationship of a plasma-derived α1-AT-C infusion to any side effects.

Methods: This was an open-label uncontrolled pharmacokinetic study. α1-AT-C was administered IV every 2 weeks for 10 infusions in 23 patients with PIZ α1-AT deficiency. Serum α1-AT levels and neutralizing elastase activity were measured preinfusion, postinfusion, and at nadir. During two infusion periods, daily serum α1-AT and neutralizing elastase activities were measured on the seventh to 14th days. Five patients received BAL assays for α1-AT and neutralizing elastase activity. Adverse events were recorded in a patient diary and by a nurse at each infusion visit.

Results: The 120-mg/kg dose of α1-AT-C could not maintain nadir serum protective levels above 70 or 80 mg/dL for the entire 14-day dosing interval in most patients. None of the patients had α1-AT levels above 80 mg/dL for all 14 days. The serum α1-AT and neutralizing elastase levels correlated suggesting functional activity. The BAL α1-AT and neutralizing elastase activities were low and did not correlate with serum levels.

Conclusion: α1-AT-C at 120 mg/kg administered every 2 weeks did not maintain nadir serum α1-AT levels above 70 to 80 mg/dL for a 14-day dosing interval. Higher doses every 2 weeks or decreased interval between infusions may be required.


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543